PT  - JOURNAL ARTICLE
AU  - Udaya Bahadur, BC
AU  - Pokharel, Sunil
AU  - Munikar, Sabika
AU  - Wagle, Chetan Nidhi
AU  - Adhikary, Pratik
AU  - Shahi, Brish Bahadur
AU  - Thapa, Chandra
AU  - Bhandari, Ram Prasad
AU  - Adhikari, Bipin
AU  - Thapa, Kanchan
TI  - Anxiety and depression among people living in quarantine centers during COVID-19 pandemic: A mixed method study from western Nepal
AID  - 10.1101/2020.11.05.20224436
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.05.20224436
4099  - http://medrxiv.org/content/early/2020/11/10/2020.11.05.20224436.short
4100  - http://medrxiv.org/content/early/2020/11/10/2020.11.05.20224436.full
AB  - Background In response to the COVID-19 pandemic, incoming travelers were quarantined at specific centers in Nepal and major checkpoints in Nepal-India border. Nepal adopted a generic public health approaches to control and quarantine returnee migrants, with little attention towards the quality of quarantine facilities and its aftermath, such as the poor mental health of the returnee migrants. The main objective of this study was to explore the status of anxiety and depression, and factors affecting them among returnee migrants living in institutional quarantine centers of western Nepal.Methods A mixed method approach was used which included a quantitative survey and in-depth interviews (IDIs). Survey questionnaire utilized Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) tools, which were administered among 441 quarantined returnee migrants and IDIs were conducted among 12 participants which included a mix of quarantined migrants and healthcare workers from the quarantine centres. Descriptive and inferential analyses were conducted on quantitative data; and thematic analysis was utilized for qualitative data.Results Mild depression (9.1%; 40/441) and anxiety (16.1%, 71/441) was common among respondents followed by moderate depression and anxiety {depression (3.4%; 15/441), anxiety (4.1%, 18/441)} and severe depression and anxiety {depression (1.1%; 5/441), anxiety (0.7%, 3/441)}. Anxiety and depression were independent of their socio-demographic characteristics. Perceived fear of contracting COVID-19, severity and death were prominent among the respondents.Respondents experienced stigma and discrimination in addition to being at the risk of disease and possible loss of employment and financial responsibilities. In addition, poor (quality and access to) health services, and poor living condition at the quarantine centres adversely affected respondents’ mental health.Conclusion Depression and anxiety among quarantined population warrants more research. Institutional quarantine centers of Karnali province of Nepal were in poor conditions which adversely impacted mental health of the respondents. Poor resources allocation for health, hygiene and living conditions can be counterproductive to the population quarantined.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThis study was funded by Ministry of Social Development (MoSD), Karnali Province of Nepal.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study obtained ethical approval from Nepal Health Research Council dated 20th April 2020 (Reference #2194). The interviews were conducted in Nepali language. A verbal informed consent was obtained from each participant and the consent was audio-recorded for IDIs. Approval from their immediate care takers were taken in case of those with age < 18 years for recruitment in this study. No financial incentive was given to the participants for their participation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll quantitative data pertaining to this study are presented in the study. Full details of qualitative data presented in this study are restricted for sharing because of the nature of breaching the anonymity due to quotes and expressions which are identifiable.ANMAuxiliary Nurse MidwifeBAIBeck Anxiety InventoryBBSBachelor in Business StudiesBDIBeck Depression InventoryBPHBachelor in Public HealthHAHealth assistantHQHome quarantineHWHealth workerMLMigrant labourMoSDMinistry of Social DevelopmentSBStreet Business